Clinical Trials Browser

Dyspnea, Multiple Myeloma, Cardiotoxicity

NCT06350994 2025-09-02

Cardio CAR-T

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Cardiomyopathies, Lymphoma, B-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Cardiotoxicity

NCT03862131 2025-07-29

PROACT

Phase 2 Terminated

49 enrolled 12 charts

BreastLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Sarcoma, Neoplasms, Plasma Cell, Cardiotoxicity

NCT03711110 2025-03-21

CARTIER

Phase NA Recruiting

514 enrolled

BreastGastrointestinalLymphoidPlasma cell

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT02178579 2020-09-14

PROTECT

Completed

95 enrolled

Plasma cell

Heart Failure, Multiple Myeloma, Cardiotoxicity

Clinical Trials

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

Cardio CAR-T

PROACT

CARTIER

PROTECT